Glomerulosclerosis in kidney transplants: pathophysiologic mechanisms.
Paul
L
L
University of Toronto, St. Michael's Hospital, Ontario.
Muralidharan
J
J
Benediktsson
H
H
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002196:Capillaries / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D017315:Cilazapril / Q000627:therapeutic use; D006084:Graft Rejection / Q000473:pathology* / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000098:blood supply / Q000473:pathology; D016030:Kidney Transplantation / Q000473:pathology* / Q000502:physiology*; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012110:Reserpine / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D014184:Transplantation, Homologous
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D017315:Cilazapril; D006830:Hydralazine; C070967:L 158809; D012110:Reserpine